Main human AOD-9604 treatment timelines Study METAOD004 Participants 36 Route Oral Treatment length 7 days Dose range 9, 27, or 54 mg/day Main lesson Short safety and tolerability study Study METAOD005 Participants 300 Route Oral Treatment length 12 weeks Dose range 1 to 30 mg/day Main lesson Earlier weight-loss trial with a non-linear dose response Study METAOD006 Participants 502 randomized Route Oral Treatment length 24 weeks Dose range 0.25, 0.5, or 1 mg/day Main lesson Primary weight-loss goal was not met The oral milligram doses in these trials cannot be converted into subcutaneous microgram doses
Initially, it was only helpful with treating the abdomen and love handles but, with the new redesigned applicators, CoolSculpting can now treat almost any body part using a specialized applicator
Do not stop taking the medication even if your symptoms improve
The mention of any brand, product, or service does not constitute an endorsement or guarantee of effectiveness or safety
Lyophilized BPC-157 typically maintains potency for 2-4 weeks at room temperature, though refrigeration extends this significantly
Some of the symptoms may include fatigue, nerve pain, sleep disturbances, moodiness, cognitive decline, and tremors